ESC 365 - Check-point inhibition: cardiovascular consequences and their prevention

ESC Premium Access

Check-point inhibition: cardiovascular consequences and their prevention

Session: Therapeutic modulation of the immune system in cardiovascular diseases

Topic: Leukocytes, Inflammation, Immunity

Speaker: Doctor J. Moslehi (San Francisco, US)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Javid Moslehi

UCSF Medical Centre, San Francisco (United States of America)

12 presentations

0 follower

4 more presentations in this session

Innate immunity mechanisms in heart failure

Speaker: Doctor S. Epelman (Toronto, CA)

Immune therapeutic targets in vascular diseases

Speaker: Professor C. Monaco (Oxford, GB)

T-cell therapeutic targets in heart failure

Speaker: Associate Professor M. Kallikourdis (Milan, IT)

Therapeutic modulation of the immune system in cardiovascular diseases - discussion

Access the full session

Therapeutic modulation of the immune system in cardiovascular diseases

Speakers: Doctor J. Moslehi, Doctor S. Epelman, Professor C. Monaco, Associate Professor M. Kallikourdis

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources